Fertility Preservation: Nonsurgical and Surgical Options

 

 Buy Article Permissions and Reprints

ABSTRACT

Improved surveillance and treatment regimens have resulted in decreased mortality rates among cancer patients, allowing these women to focus on survival and quality of life, including the ability to preserve their fertility. The treatments that have improved survival among both adults and children diagnosed with cancer are often gonadotoxic, especially those that employ high doses of alkylating agents and radiation therapy directed near or toward the pelvis. The impact on the ovarian reserve is related to the accelerated depletion of the primordial germ cell pool resulting from these therapies. Nonsurgical approaches to fertility preservation, including embryo cryopreservation from in vitro fertilization, oocyte cryopreservation from controlled ovarian hyperstimulation, and in vitro maturation of oocytes, are discussed. Surgical approaches such as conservative gynecologic surgery, ovarian transposition, and ovarian tissue cryopreservation are reviewed. Guidelines from the American Society for Reproductive Medicine and the American Society of Clinical Oncology classify these treatments into established and experimental procedures, and they provide the practitioner with an optimal approach to preserve the fertility of these patients before the initiation of their cancer therapies.

REFERENCES

• 1 Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009.  CA Cancer J Clin. 2009;  59 (4) 225-249
  CrossrefPubMedGoogle Scholar
• 2 Bleyer W A. The impact of childhood cancer on the United States and the world.  CA Cancer J Clin. 1990;  40 (6) 355-367
  CrossrefPubMedGoogle Scholar
• 3 Speroff L, Fritz M. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005
  Google Scholar
• 4 Bokemeyer C, Schmoll H J, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.  Ann Hematol. 1994;  68 (3) 105-110
  CrossrefPubMedGoogle Scholar
• 5 Lobo R A. Potential options for preservation of fertility in women.  N Engl J Med. 2005;  353 (1) 64-73
  CrossrefPubMedGoogle Scholar
• 6 Grigsby P W, Russell A, Bruner D et al. Late injury of cancer therapy on the female reproductive tract.  Int J Radiat Oncol Biol Phys. 1995;  31 (5) 1281-1299
  CrossrefPubMedGoogle Scholar
• 7 Crictchley H, Hamish B. Safety of pregnancy during and after cancer treatment.  J Natl Cancer Inst Monogr. 2005;  34 64
  PubMedGoogle Scholar
• 8 Wallace W H, Thomson A B, Saran F, Kelsey T W. Predicting age of ovarian failure after radiation to a field that includes the ovaries.  Int J Radiat Oncol Biol Phys. 2005;  62 (3) 738-744
  CrossrefPubMedGoogle Scholar
• 9 Mattle V, Behringer K, Engert A, Wildt L. Female fertility after cytotoxic therapy—protection of ovarian function during chemotherapy of malignant and non-malignant diseases.  Eur J Haematol Suppl. 2005;  66 (66) 77-82
  PubMedGoogle Scholar
• 10 Slavin S, Nagler A, Aker M, Shapira M Y, Cividalli G, Or R. Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.  Rev Clin Exp Hematol. 2001;  5 (2) 135-146
  CrossrefPubMedGoogle Scholar
• 11 Ethics Committee of the American Society for Reproductive Medicine . Fertility preservation and reproduction in cancer patients.  Fertil Steril. 2005;  83 (6) 1622-1628
  CrossrefPubMedGoogle Scholar
• 12 Lee S J, Schover L R, Partridge A H American Society of Clinical Oncology et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.  J Clin Oncol. 2006;  24 (18) 2917-2931
  CrossrefPubMedGoogle Scholar
• 13 Centers for Disease Control and Prevention .Assisted reproductive technology success rates: national summary and fertility clinic reports. Available at: http://www.sart.org
  Google Scholar
• 14 Yue W, Santen R J, Wang J P et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.  J Steroid Biochem Mol Biol. 2003;  86 (3–5) 477-486
  CrossrefPubMedGoogle Scholar
• 15 Oktay K, Hourvitz A, Sahin G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.  J Clin Endocrinol Metab. 2006;  91 (10) 3885-3890
  CrossrefPubMedGoogle Scholar
• 16 Porcu E, Venturoli S. Progress with oocyte cryopreservation.  Curr Opin Obstet Gynecol. 2006;  18 (3) 273-279
  CrossrefPubMedGoogle Scholar
• 17 Chen S U, Lien Y R, Chao K H, Ho H N, Yang Y S, Lee T Y. Effects of cryopreservation on meiotic spindles of oocytes and its dynamics after thawing: clinical implications in oocyte freezing—a review article.  Mol Cell Endocrinol. 2003;  202 (1–2) 101-107
  CrossrefPubMedGoogle Scholar
• 18 Vincent C, Pickering S J, Johnson M H. The hardening effect of dimethylsulphoxide on the mouse zona pellucida requires the presence of an oocyte and is associated with a reduction in the number of cortical granules present.  J Reprod Fertil. 1990;  89 (1) 253-259
  PubMedGoogle Scholar
• 19 Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: new perspectives regarding oocyte survival.  Hum Reprod. 2001;  16 (3) 411-416
  CrossrefPubMedGoogle Scholar
• 20 Kinzer D, Alper M, Barrett B. Donor oocyte cryopreservation and subsequent pre-implentation genetic diagnosis of resulting embryos results in high pregnancy rates with a minimum number of embryos transferred.  Fertil Steril. 2008;  90 (Suppl 1) 524
  PubMedGoogle Scholar
• 21 Grifo J A, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients.  Fertil Steril. 2010;  93 (2) 391-396
  CrossrefPubMedGoogle Scholar
• 22 Huang J Y, Tulandi T, Holzer H, Tan S L, Chian R C. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.  Fertil Steril. 2008;  89 (3) 567-572
  CrossrefPubMedGoogle Scholar
• 23 Surveillance, Epidemiology and End Results. Available at: http://seer.cancer.gov
  Google Scholar
• 24 Magrina J F, Goodrich M A, Weaver A L, Podratz K C. Modified radical hysterectomy: morbidity and mortality.  Gynecol Oncol. 1995;  59 (2) 277-282
  CrossrefPubMedGoogle Scholar
• 25 Gien L T, Covens A. Fertility-sparing options for early stage cervical cancer.  Gynecol Oncol. 2010;  117 (2) 350-357
  CrossrefPubMedGoogle Scholar
• 26 Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients.  Cancer. 2000;  88 (8) 1877-1882
  CrossrefPubMedGoogle Scholar
• 27 Shepherd J H, Mould T, Oram D H. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates.  BJOG. 2001;  108 (8) 882-885
  CrossrefPubMedGoogle Scholar
• 28 Shepherd J H, Spencer C, Herod J, Ind T E. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer—cumulative pregnancy rate in a series of 123 women.  BJOG. 2006;  113 (6) 719-724
  Google Scholar
• 29 Plante M, Renaud M C, François H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature.  Gynecol Oncol. 2004;  94 (3) 614-623
  Google Scholar
• 30 Hertel H, Köhler C, Grund D German Association of Gynecologic Oncologists (AGO) et al. Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer.  Gynecol Oncol. 2006;  103 (2) 506-511
  Google Scholar
• 31 Plante M. Vaginal radical trachelectomy: an update.  Gynecol Oncol. 2008;  111 (2 Suppl) S105-S110
  CrossrefPubMedGoogle Scholar
• 32 Marchiole P, Benchaib M, Buenerd A, Lazlo E, Dargent D, Mathevet P. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH).  Gynecol Oncol. 2007;  106 (1) 132-141
  Google Scholar
• 33 Covens A, Rosen B, Murphy J et al. How important is removal of the parametrium at surgery for carcinoma of the cervix?.  Gynecol Oncol. 2002;  84 (1) 145-149
  CrossrefPubMedGoogle Scholar
• 34 Stegeman M, Louwen M, van der Velden J et al. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy.  Gynecol Oncol. 2007;  105 (2) 475-480
  CrossrefPubMedGoogle Scholar
• 35 Rob L, Charvat M, Robova H et al. Less radical fertility-sparing surgery than radical trachelectomy in early cervical cancer.  Int J Gynecol Cancer. 2007;  17 (1) 304-310
  Google Scholar
• 36 Bisseling K C, Bekkers R L, Rome R M, Quinn M A. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.  Gynecol Oncol. 2007;  107 (3) 424-430
  CrossrefPubMedGoogle Scholar
• 37 Milliken D A, Shepherd J H. Fertility preserving surgery for carcinoma of the cervix.  Curr Opin Oncol. 2008;  20 (5) 575-580
  CrossrefPubMedGoogle Scholar
• 38 Boss E A, van Golde R J, Beerendonk C C, Massuger L F. Pregnancy after radical trachelectomy: a real option?.  Gynecol Oncol. 2005;  99 (3 Suppl 1) S152-S156
  CrossrefPubMedGoogle Scholar
• 39 Chiva L, Lapuente F, González-Cortijo L et al. Sparing fertility in young patients with endometrial cancer.  Gynecol Oncol. 2008;  111 (2 Suppl) S101-S104
  CrossrefPubMedGoogle Scholar
• 40 Kim Y B, Holschneider C H, Ghosh K, Nieberg R K, Montz F J. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature.  Cancer. 1997;  79 (2) 320-327
  CrossrefPubMedGoogle Scholar
• 41 Ushijima K, Yahata H, Yoshikawa H et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.  J Clin Oncol. 2007;  25 (19) 2798-2803
  CrossrefPubMedGoogle Scholar
• 42 Kauff N D. How should women with early-onset endometrial cancer be evaluated for Lynch syndrome?.  J Clin Oncol. 2007;  25 (33) 5143-5146
  CrossrefPubMedGoogle Scholar
• 43 Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer.  Obstet Gynecol. 2005;  106 (4) 693-699
  CrossrefPubMedGoogle Scholar
• 44 Simon B, Lee S J, Partridge A H, Runowicz C D. Preserving fertility after cancer.  CA Cancer J Clin. 2005;  55 (4) 211-228 quiz 263-264
  CrossrefPubMedGoogle Scholar
• 45 Schilder J M, Thompson A M, DePriest P D et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.  Gynecol Oncol. 2002;  87 (1) 1-7
  CrossrefPubMedGoogle Scholar
• 46 Marhhom E, Cohen I. Fertility preservation options for women with malignancies.  Obstet Gynecol Surv. 2007;  62 (1) 58-72
  CrossrefPubMedGoogle Scholar
• 47 Scott S M, Schlaff W. Laparoscopic medial oophoropexy prior to radiation therapy in an adolescent with Hodgkin's disease.  J Pediatr Adolesc Gynecol. 2005;  18 (5) 355-357
  CrossrefPubMedGoogle Scholar
• 48 Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination.  Fertil Steril. 2000;  74 (4) 743-748
  CrossrefPubMedGoogle Scholar
• 49 Kuohung W, Ram K, Cheng D M, Marcus K J, Diller L R, Laufer M R. Laparoscopic oophoropexy prior to radiation for pediatric brain tumor and subsequent ovarian function.  Hum Reprod. 2008;  23 (1) 117-121
  CrossrefPubMedGoogle Scholar
• 50 Williams R S, Littell R D, Mendenhall N P. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease.  Cancer. 1999;  86 (10) 2138-2142
  CrossrefPubMedGoogle Scholar
• 51 Guglielmi R, Calzavara F, Pizzi G B et al. Ovarian function after pelvic lymph node irradiation in patients with Hodgkin's disease submitted to oophoropexy during laparotomy.  Eur J Gynaecol Oncol. 1980;  1 (2) 99-107
  PubMedGoogle Scholar
• 52 Khan M A, Dahill S W, Stewart K S. Primary Hodgkin's disease of the ovary. Case report.  Br J Obstet Gynaecol. 1986;  93 (12) 1300-1301
  PubMedGoogle Scholar
• 53 Osborne B M, Robboy S J. Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases.  Cancer. 1983;  52 (10) 1933-1943
  CrossrefPubMedGoogle Scholar
• 54 Meirow D, Hardan I, Dor J et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.  Hum Reprod. 2008;  23 (5) 1007-1013
  CrossrefPubMedGoogle Scholar
• 55 Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience.  Fertil Steril. 2010;  93 (3) 762-768
  CrossrefPubMedGoogle Scholar
• 56 Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans M M. Ovarian tissue cryopreservation and transplantation: a review.  Hum Reprod Update. 2006;  12 (5) 519-535
  CrossrefPubMedGoogle Scholar
• 57 Donnez J, Dolmans M M, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.  Lancet. 2004;  364 (9443) 1405-1410
  CrossrefPubMedGoogle Scholar
• 58 Meirow D, Levron J, Eldar-Geva T et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.  N Engl J Med. 2005;  353 (3) 318-321
  CrossrefPubMedGoogle Scholar
• 59 Andersen C Y, Rosendahl M, Byskov A G et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue.  Hum Reprod. 2008;  23 (10) 2266-2272
  CrossrefPubMedGoogle Scholar
• 60 Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease.  Oncologist. 2007;  12 (12) 1437-1442
  CrossrefPubMedGoogle Scholar
• 61 Oktay K, Buyuk E, Veeck L et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue.  Lancet. 2004;  363 (9412) 837-840
  CrossrefPubMedGoogle Scholar
• 62 Sonmezer M, Oktay K. Fertility preservation in female patients.  Hum Reprod Update. 2004;  10 (3) 251-266
  CrossrefPubMedGoogle Scholar
• 63 Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation.  Hum Reprod. 2004;  19 (3) 477-480
  CrossrefPubMedGoogle Scholar
• 64 Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm.  JAMA. 2001;  286 (12) 1490-1493
  CrossrefPubMedGoogle Scholar
• 65 Jadoul P, Donnez J, Dolmans M M, Squifflet J, Lengele B, Martinez-Madrid B. Laparoscopic ovariectomy for whole human ovary cryopreservation: technical aspects.  Fertil Steril. 2007;  87 (4) 971-975
  CrossrefPubMedGoogle Scholar

Stephanie N MorrisM.D. 

Associate Director, Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Newton-Wellesley Hospital; Clinical Instructor, Harvard Medical School

NWH, MIGS Center, 2014 Washington Street, Newton, MA 02461

Email: snmorris@partners.org